TNGX
Tango Therapeutics Inc

685
Mkt Cap
$1.68B
Volume
655,641.00
52W High
$13.46
52W Low
$1.03
PE Ratio
-13.65
TNGX Fundamentals
Price
$12.92
Prev Close
$12.51
Open
$12.47
50D MA
$10.43
Beta
1.19
Avg. Volume
3.19M
EPS (Annual)
-$1.19
P/B
8.72
Rev/Employee
$271,412.90
$116.09
Loading...
Loading...
News
all
press releases
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight brokerages that are presently covering the stock, MarketBeat...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Expert Outlook: Tango Therapeutics Through The Eyes Of 4 Analysts
read more...
Benzinga·3d ago
News Placeholder
Guggenheim Issues Positive Forecast for Tango Therapeutics (NASDAQ:TNGX) Stock Price
Guggenheim increased their price target on shares of Tango Therapeutics from $12.00 to $18.00 and gave the company a "buy" rating in a report on Friday...
MarketBeat·3d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Director Barbara Weber Sells 30,519 Shares
Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) Director Barbara Weber sold 30,519 shares of the firm's stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average...
MarketBeat·4d ago
News Placeholder
Great Lakes Advisors LLC Invests $3.56 Million in Tango Therapeutics, Inc. $TNGX
Great Lakes Advisors LLC purchased a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·9d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Sets New 52-Week High - What's Next?
Tango Therapeutics (NASDAQ:TNGX) Sets New 1-Year High - Time to Buy...
MarketBeat·19d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Sets New 52-Week High - Here's Why
Tango Therapeutics (NASDAQ:TNGX) Hits New 12-Month High - What's Next...
MarketBeat·25d ago
News Placeholder
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the firm, Marketbeat.com...
MarketBeat·25d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Trading 8.3% Higher - Should You Buy?
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 8.3% - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 8.4% - What's Next?
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 8.4% - What's Next...
MarketBeat·28d ago
<
1
2
...
>

Latest TNGX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.